Literature DB >> 18033677

Nilvadipine prevents cognitive decline of patients with mild cognitive impairment.

Haruo Hanyu, Kentaro Hirao, Soichiro Shimizu, Tomohiko Sato, Akihiro Kiuchi, Toshihiko Iwamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033677     DOI: 10.1002/gps.1851

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


× No keyword cloud information.
  17 in total

1.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 2.  Blood-brain barrier dysfunction: the undervalued frontier of hypertension.

Authors:  Vasiliki Katsi; Maria Marketou; Spyridon Maragkoudakis; Matthaios Didagelos; Georgios Charalambous; Fragkiskos Parthenakis; Costas Tsioufis; Dimitrios Tousoulis
Journal:  J Hum Hypertens       Date:  2020-05-18       Impact factor: 3.012

Review 3.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 4.  Pharmacotherapy for Vascular Cognitive Impairment.

Authors:  Muhammad U Farooq; Jiangyong Min; Christopher Goshgarian; Philip B Gorelick
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 5.  Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Authors:  Thimmappa S Anekonda; Joseph F Quinn
Journal:  Biochim Biophys Acta       Date:  2011-09-08

6.  Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.

Authors:  Daniel Paris; Corbin Bachmeier; Nikunj Patel; Amita Quadros; Claude-Henry Volmar; Vincent Laporte; Jim Ganey; David Beaulieu-Abdelahad; Ghania Ait-Ghezala; Fiona Crawford; Michael J Mullan
Journal:  Mol Med       Date:  2010-12-17       Impact factor: 6.354

Review 7.  Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.

Authors:  Tae-Wan Kim
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

8.  Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo.

Authors:  Morrie Lam; Natalia Mast; Irina A Pikuleva
Journal:  Mol Pharmacol       Date:  2017-11-30       Impact factor: 4.436

Review 9.  Calcium channel blockers and dementia.

Authors:  V Nimmrich; A Eckert
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.

Authors:  Mauro Cataldi
Journal:  Curr Neuropharmacol       Date:  2013-05       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.